Jaguar Health (JAGX) Operating Leases (2019 - 2026)
Jaguar Health (JAGX) posted quarterly Operating Leases of $898000.0 for Q1 2026, down 10.02% year-over-year from $998000.0 in Q1 2025, and up 0.67% quarter-over-quarter from $892000.0 in Q4 2025.
Jaguar Health (JAGX) Operating Leases (2019 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Operating Leases for 7 consecutive years, with $898000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Leases fell 10.02% year-over-year to $898000.0; the TTM figure through Mar 2026 stood at $898000.0 (down 10.02% YoY), while the FY2025 annual figure was $892000.0, up 30.03% from the prior year.
- Operating Leases advanced to $898000.0 in Q1 2026 per JAGX's latest filing, from $892000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $998000.0 in Q1 2025 and bottomed at $351000.0 in Q3 2023.
- Historically, Operating Leases has averaged $788352.9 across 5 years, with a median of $868000.0 in 2022.
- Annual changes were most pronounced in 2023 — Operating Leases tumbled 52.44% — and 2024, when it soared 114.81%.
- Jaguar Health's Operating Leases stood at $725000.0 in 2022, then gained by 22.21% to $886000.0 in 2023, then decreased by 22.57% to $686000.0 in 2024, then soared by 30.03% to $892000.0 in 2025, then increased by 0.67% to $898000.0 in 2026.
- Business Quant data shows JAGX's Operating Leases at $898000.0 in Q1 2026, $892000.0 in Q4 2025, and $918000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Jaguar Health | 447,549.24 | -9.62 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 898,000.00 |
| Dec 31, 2025 | 892,000.00 |
| Sep 30, 2025 | 918,000.00 |
| Jun 30, 2025 | 960,000.00 |
| Mar 31, 2025 | 998,000.00 |
| Dec 31, 2024 | 686,000.00 |
| Sep 30, 2024 | 754,000.00 |
| Jun 30, 2024 | 812,000.00 |
| Mar 31, 2024 | 873,000.00 |
| Dec 31, 2023 | 886,000.00 |
| Sep 30, 2023 | 351,000.00 |
| Jun 30, 2023 | 495,000.00 |
| Mar 31, 2023 | 627,000.00 |
| Dec 31, 2022 | 725,000.00 |
| Sep 30, 2022 | 738,000.00 |
| Jun 30, 2022 | 868,000.00 |
| Mar 31, 2022 | 921,000.00 |
| Dec 31, 2021 | 919,000.00 |
| Sep 30, 2021 | 826,000.00 |
| Jun 30, 2021 | 907,000.00 |